Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults

L. Gualco, E. A. Debbia, R. Bandettini, L. Pescetto, A. Cavallero, M. C. Ossi, A. M. Schito, A. Marchese

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

The activity of amphotericin B, fluconazole, flucytosine, itraconazole and voriconazole was tested in vitro against 618 clinical Candida spp. isolates, using the broth microdilution or the disk diffusion method (voriconazole). Amphotericin B and voriconazole were the most potent antifungal agents assayed (100% of susceptible strains). Resistance to fluconazole and itraconazole was detected in three (0.7%) and 11 (2.7%) isolates of Candida albicans and in four (3.7%) isolates of Candida glabrata. Flucytosine intermediate, resistant strains, or both, were observed in C. albicans (0.3% and 0.7%), C. glabrata (2.8% intermediate) and C. tropicalis (15.2% and 15.2%). C. krusei was the least susceptible species to azoles. No statistically significant differences in the rates of resistant isolates depending on site of infection and age of the patient were observed, with the exception of C. albicans and itraconazole (higher percentage of resistance in children). At present, acquired antifungal resistance represents an uncommon finding in most Candida spp. circulating in Northern Italy.

Original languageEnglish
Pages (from-to)179-184
Number of pages6
JournalInternational Journal of Antimicrobial Agents
Volume29
Issue number2
DOIs
Publication statusPublished - Feb 2007

Fingerprint

Itraconazole
Candida albicans
Candida
Italy
Candida glabrata
Flucytosine
Fluconazole
Amphotericin B
Azoles
Antifungal Agents
Infection
Voriconazole

Keywords

  • Antifungal agent
  • Azoles
  • C. albicans
  • MIC
  • Yeast

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Microbiology
  • Parasitology
  • Virology
  • Immunology and Allergy
  • Infectious Diseases

Cite this

Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults. / Gualco, L.; Debbia, E. A.; Bandettini, R.; Pescetto, L.; Cavallero, A.; Ossi, M. C.; Schito, A. M.; Marchese, A.

In: International Journal of Antimicrobial Agents, Vol. 29, No. 2, 02.2007, p. 179-184.

Research output: Contribution to journalArticle

Gualco, L. ; Debbia, E. A. ; Bandettini, R. ; Pescetto, L. ; Cavallero, A. ; Ossi, M. C. ; Schito, A. M. ; Marchese, A. / Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults. In: International Journal of Antimicrobial Agents. 2007 ; Vol. 29, No. 2. pp. 179-184.
@article{789bdc49d52341b89cf0d5560ff20394,
title = "Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults",
abstract = "The activity of amphotericin B, fluconazole, flucytosine, itraconazole and voriconazole was tested in vitro against 618 clinical Candida spp. isolates, using the broth microdilution or the disk diffusion method (voriconazole). Amphotericin B and voriconazole were the most potent antifungal agents assayed (100{\%} of susceptible strains). Resistance to fluconazole and itraconazole was detected in three (0.7{\%}) and 11 (2.7{\%}) isolates of Candida albicans and in four (3.7{\%}) isolates of Candida glabrata. Flucytosine intermediate, resistant strains, or both, were observed in C. albicans (0.3{\%} and 0.7{\%}), C. glabrata (2.8{\%} intermediate) and C. tropicalis (15.2{\%} and 15.2{\%}). C. krusei was the least susceptible species to azoles. No statistically significant differences in the rates of resistant isolates depending on site of infection and age of the patient were observed, with the exception of C. albicans and itraconazole (higher percentage of resistance in children). At present, acquired antifungal resistance represents an uncommon finding in most Candida spp. circulating in Northern Italy.",
keywords = "Antifungal agent, Azoles, C. albicans, MIC, Yeast",
author = "L. Gualco and Debbia, {E. A.} and R. Bandettini and L. Pescetto and A. Cavallero and Ossi, {M. C.} and Schito, {A. M.} and A. Marchese",
year = "2007",
month = "2",
doi = "10.1016/j.ijantimicag.2006.08.047",
language = "English",
volume = "29",
pages = "179--184",
journal = "International Journal of Antimicrobial Agents",
issn = "0924-8579",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults

AU - Gualco, L.

AU - Debbia, E. A.

AU - Bandettini, R.

AU - Pescetto, L.

AU - Cavallero, A.

AU - Ossi, M. C.

AU - Schito, A. M.

AU - Marchese, A.

PY - 2007/2

Y1 - 2007/2

N2 - The activity of amphotericin B, fluconazole, flucytosine, itraconazole and voriconazole was tested in vitro against 618 clinical Candida spp. isolates, using the broth microdilution or the disk diffusion method (voriconazole). Amphotericin B and voriconazole were the most potent antifungal agents assayed (100% of susceptible strains). Resistance to fluconazole and itraconazole was detected in three (0.7%) and 11 (2.7%) isolates of Candida albicans and in four (3.7%) isolates of Candida glabrata. Flucytosine intermediate, resistant strains, or both, were observed in C. albicans (0.3% and 0.7%), C. glabrata (2.8% intermediate) and C. tropicalis (15.2% and 15.2%). C. krusei was the least susceptible species to azoles. No statistically significant differences in the rates of resistant isolates depending on site of infection and age of the patient were observed, with the exception of C. albicans and itraconazole (higher percentage of resistance in children). At present, acquired antifungal resistance represents an uncommon finding in most Candida spp. circulating in Northern Italy.

AB - The activity of amphotericin B, fluconazole, flucytosine, itraconazole and voriconazole was tested in vitro against 618 clinical Candida spp. isolates, using the broth microdilution or the disk diffusion method (voriconazole). Amphotericin B and voriconazole were the most potent antifungal agents assayed (100% of susceptible strains). Resistance to fluconazole and itraconazole was detected in three (0.7%) and 11 (2.7%) isolates of Candida albicans and in four (3.7%) isolates of Candida glabrata. Flucytosine intermediate, resistant strains, or both, were observed in C. albicans (0.3% and 0.7%), C. glabrata (2.8% intermediate) and C. tropicalis (15.2% and 15.2%). C. krusei was the least susceptible species to azoles. No statistically significant differences in the rates of resistant isolates depending on site of infection and age of the patient were observed, with the exception of C. albicans and itraconazole (higher percentage of resistance in children). At present, acquired antifungal resistance represents an uncommon finding in most Candida spp. circulating in Northern Italy.

KW - Antifungal agent

KW - Azoles

KW - C. albicans

KW - MIC

KW - Yeast

UR - http://www.scopus.com/inward/record.url?scp=33846042738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846042738&partnerID=8YFLogxK

U2 - 10.1016/j.ijantimicag.2006.08.047

DO - 10.1016/j.ijantimicag.2006.08.047

M3 - Article

VL - 29

SP - 179

EP - 184

JO - International Journal of Antimicrobial Agents

JF - International Journal of Antimicrobial Agents

SN - 0924-8579

IS - 2

ER -